Clinical trial
MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or…
NCT00008437 · InSightec, Industry · Completed
Key facts
| NCT number | NCT00008437 |
|---|---|
| Title | MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer |
| Official title | Pilot Study of MR-Guided Focused Ultrasound for Tissue Coagulation in Women With Breast Cancer: MR Imaging and Histopathic Correlation, An Assessment or Target Accuracy and Patient Acceptance |
| Lead sponsor | InSightec, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Device |
| Interventions | high-intensity focused ultrasound ablation |
| Start date | Dec 1, 2000 |
| Primary completion | Dec 1, 2000 |
| Completion | Dec 1, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 2, 2012 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: